Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.

[1]  R. Colman,et al.  Invited letter concerning: aprotinin. , 1991, The Journal of thoracic and cardiovascular surgery.

[2]  J. Soria,et al.  Temperature dependence of plasmin-induced activation or inhibition of human platelets. , 1991, Blood.

[3]  C. Soria,et al.  Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation. , 1991, Blood.

[4]  A. Michelson,et al.  Plasmin-induced redistribution of platelet glycoprotein Ib. , 1990, Blood.

[5]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[6]  I. Goel,et al.  Prophylactic tranexamic acid decreases bleeding after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.

[7]  A. Vaheri,et al.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants , 1989, The Journal of cell biology.

[8]  B. Adelman,et al.  Plasminogen interactions with platelets in plasma , 1988 .

[9]  E. Plow,et al.  The cell-binding domains of plasminogen and their function in plasma. , 1988, Journal of Biological Chemistry.

[10]  K. Sletten,et al.  Competitions between fibrinogen with its degradation products for interactions with the platelet-fibrinogen receptor. , 1986, Thrombosis research.

[11]  D. T. Shiu,et al.  Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. , 1986, Blood.

[12]  J. White,et al.  Plasminogen interacts with human platelets through two distinct mechanisms. , 1986, The Journal of clinical investigation.

[13]  D. Cosgrove.  An improved technique for autotransfusion of shed mediastinal blood. , 1985, Health matrix.

[14]  R. Wilson,et al.  Hemostasis Changes During Cardiopulmonary Bypass Surgery , 1985, Seminars in thrombosis and hemostasis.

[15]  L. Eysman,et al.  Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusions. , 1985, The Journal of thoracic and cardiovascular surgery.

[16]  E. Plow,et al.  Binding and activation of plasminogen on the platelet surface. , 1985, The Journal of biological chemistry.

[17]  J. Loscalzo,et al.  Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions. , 1985, Blood.

[18]  C. Kluft,et al.  Enhanced fibrinolytic activity during cardiopulmonary bypass in open‐heart surgery in man is caused by extrinsic (tissue‐type) plasminogen activator , 1984, European journal of clinical investigation.

[19]  J. Verheijen,et al.  Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments. , 1982, Thrombosis research.

[20]  M. Hoylaerts,et al.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.